Pharmacokinetics and safety of panitumumab in a patient with chronic kidney disease

PURPOSE: Data on panitumumab dosing in cancer patients with renal insufficiency are lacking. Here, we report a 63-year-old metastatic colorectal cancer patient with chronic kidney injury with a glomerular filtration rate of approximately 11 mL/min. METHODS: Pharmacokinetic parameters, including dose...

Descripción completa

Detalles Bibliográficos
Autores principales: Krens, L. L., Baas, J. M., Guchelaar, H. J., Gelderblom, H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5754392/
https://www.ncbi.nlm.nih.gov/pubmed/29170802
http://dx.doi.org/10.1007/s00280-017-3479-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5754392/
https://www.ncbi.nlm.nih.gov/pubmed/29170802
http://dx.doi.org/10.1007/s00280-017-3479-2

Ejemplares similares